# Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas

Source: https://onco.cc/trials/nct03178032/  
OnCo record `nct03178032` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of DNX-2401 run by Clinica Universidad de Navarra, Universidad de Navarra, completed.

## Summary

Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas is a phase 1 interventional study registered as NCT03178032 by Clinica Universidad de Navarra, Universidad de Navarra, with 12 participants enrolled, started 2017-05-26. Conditions recorded: Brainstem Glioma and Neoadjuvant Therapy. Interventions recorded: DNX-2401.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT03178032
- Phase: 1
- Setting: Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients.
- Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
- Enrolled: 12

## Sources

- ClinicalTrials.gov NCT03178032: https://clinicaltrials.gov/study/NCT03178032

## Connected records

- cancers: [Brain and spinal cord tumours (all types)](https://onco.cc/cancers/brain-tumours/)
- drugs: [DNX-2401](https://onco.cc/drugs/dnx-2401/)
- companies: [DNAtrix](https://onco.cc/companies/dnatrix/)

---
JSON: https://onco.cc/api/v1/entities/nct03178032.json